Tags » Journal Articles

The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand

from Latest Results for Applied Health Economics and Health Policy at http://bit.ly/1pSSBjq on August 21, 2014 at 01:00AM

Abstract

Background

Concerns about the long-term sustainability of health care expenditures (HCEs), particularly prescribing expenditures, has become an important policy issue in most developed countries. 321 more words

HealthEconJA

The effect of social health insurance on prenatal care: the case of Ghana

from Latest Results for International Journal of Health Care Finance and Economics at http://bit.ly/1to7Cu7 on August 21, 2014 at 01:00AM

Abstract

Many developing countries have introduced social health insurance programs to help address two of the United Nations’ millennium development goals—reducing infant mortality and improving maternal health outcomes. 121 more words

HealthEconJA

Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability

from Informa Healthcare: Expert Review of Pharmacoeconomics & Outcomes Research: Table of Contents at http://bit.ly/1kWTpEc on August 20, 2014 at 11:59AM


Expert Review of Pharmacoeconomics & Outcomes Research, Ahead of Print.

HealthEconJA

The cost–effectiveness of infliximab in Crohn’s disease

from Informa Healthcare: Expert Review of Pharmacoeconomics & Outcomes Research: Table of Contents at http://bit.ly/1kWTrf4 on August 20, 2014 at 08:34AM


Expert Review of Pharmacoeconomics & Outcomes Research, Ahead of Print.

HealthEconJA

The Nocturia Impact Diary: A Self-Reported Impact Measure to Complement the Voiding Diary

from ScienceDirect Publication: Value in Health at http://bit.ly/XBQFSv on August 21, 2014 at 04:48AM


Publication date:
Source:Value in Health
Author(s): Tove Holm-Larsen , Fredrik Andersson , Egbert van der Meulen , Vladimir Yankov , Raymond C. Rosen , Jens Peter Nørgaard

HealthEconJA

Costs and utilization of hemophilia A and B patients with and without inhibitors

from Informa Healthcare: Journal of Medical Economics: Table of Contents at http://bit.ly/1vhb8a8 on August 20, 2014 at 01:48PM


Journal of Medical Economics, Ahead of Print.

HealthEconJA

Costs and utilization of hemophilia A and B patients with and without inhibitors

from Informa Healthcare: Journal of Medical Economics: Table of Contents at http://bit.ly/1vhb8a8 on August 20, 2014 at 01:48PM


Journal of Medical Economics, Ahead of Print.

HealthEconJA